190 related articles for article (PubMed ID: 10654903)
1. Adjuvant treatment of clinical stage I seminoma: is a single course of carboplatin sufficient?
Dieckmann KP; Brüggeboes B; Pichlmeier U; Küster J; Müllerleile U; Bartels H
Urology; 2000 Jan; 55(1):102-6. PubMed ID: 10654903
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant carboplatin treatment for seminoma clinical stage I.
Dieckmann KP; Krain J; Küster J; Brüggeboes B
J Cancer Res Clin Oncol; 1996; 122(1):63-6. PubMed ID: 8543595
[TBL] [Abstract][Full Text] [Related]
3. Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone.
Patterson H; Norman AR; Mitra SS; Nicholls J; Fisher C; Dearnaley DP; Horwich A; Mason MD; Huddart RA
Radiother Oncol; 2001 Apr; 59(1):5-11. PubMed ID: 11295200
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial.
Oliver RT; Mason MD; Mead GM; von der Maase H; Rustin GJ; Joffe JK; de Wit R; Aass N; Graham JD; Coleman R; Kirk SJ; Stenning SP;
Lancet; 2005 Jul 23-29; 366(9482):293-300. PubMed ID: 16039331
[TBL] [Abstract][Full Text] [Related]
5. Two cycles of adjuvant carboplatin in stage I seminoma: 8-year experience by the Hellenic Cooperative Oncology Group (HECOG).
Koutsoukos K; Tzannis K; Christodoulou C; Karavasilis V; Bakoyiannis C; Makatsoris T; Papandreou CN; Pectasides D; Dimopoulos MA; Bamias A
World J Urol; 2016 Jun; 34(6):853-7. PubMed ID: 26410826
[TBL] [Abstract][Full Text] [Related]
6. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
[TBL] [Abstract][Full Text] [Related]
7. Sperm analysis and serum follicle-stimulating hormone levels before and after adjuvant single-agent carboplatin therapy for clinical stage I seminoma.
Reiter WJ; Kratzik C; Brodowicz T; Haitel A; Pokorny A; Zielinski CC; Marberger M
Urology; 1998 Jul; 52(1):117-9. PubMed ID: 9671881
[TBL] [Abstract][Full Text] [Related]
8. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.
Aparicio J; Germà JR; García del Muro X; Maroto P; Arranz JA; Sáenz A; Barnadas A; Dorca J; Gumà J; Olmos D; Bastús R; Carles J; Almenar D; Sánchez M; Paz-Ares L; Satrústegui JJ; Mellado B; Balil A; López-Brea M; Sánchez A;
J Clin Oncol; 2005 Dec; 23(34):8717-23. PubMed ID: 16260698
[TBL] [Abstract][Full Text] [Related]
9. Twelve-year experience with two courses of adjuvant single-agent carboplatin therapy for clinical stage I seminoma.
Reiter WJ; Brodowicz T; Alavi S; Zielinski CC; Kozak W; Maier U; Nöst G; Lipsky H; Marberger M; Kratzik C
J Clin Oncol; 2001 Jan; 19(1):101-4. PubMed ID: 11134201
[TBL] [Abstract][Full Text] [Related]
10. Late relapse of stage i seminoma following single-agent carboplatin.
Raj S; Williams MV; Dixon AK; Robson J; Mazhar D
Oncology; 2007; 73(5-6):419-21. PubMed ID: 18515983
[TBL] [Abstract][Full Text] [Related]
11. [Radiotherapy in stage I testicular seminoma: retrospective study and review of literature].
Bauduceau O; Souleau B; Le-Moulec S; Houlgatte A; Bernard O
Cancer Radiother; 2003 Dec; 7(6):386-94. PubMed ID: 14725912
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214).
Oliver RT; Mead GM; Rustin GJ; Joffe JK; Aass N; Coleman R; Gabe R; Pollock P; Stenning SP
J Clin Oncol; 2011 Mar; 29(8):957-62. PubMed ID: 21282539
[TBL] [Abstract][Full Text] [Related]
13. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
14. Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma.
Fischer S; Tandstad T; Wheater M; Porfiri E; Fléchon A; Aparicio J; Klingbiel D; Skrbinc B; Basso U; Shamash J; Lorch A; Dieckmann KP; Cohn-Cedermark G; Ståhl O; Chau C; Arriola E; Marti K; Hutton P; Laguerre B; Maroto P; Beyer J; Gillessen S
J Clin Oncol; 2017 Jan; 35(2):194-200. PubMed ID: 27893332
[TBL] [Abstract][Full Text] [Related]
15. An alternative treatment regimen of advanced seminoma with carboplatin, etoposide, and bleomycin instead of cisplatin-based therapy.
Giesen E; Mager A; van Tinteren H; Rodenhuis S; Kerst JM
Urol Oncol; 2013 Jan; 31(1):110-4. PubMed ID: 21458311
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey.
Diminutto A; Basso U; Maruzzo M; Morelli F; De Giorgi U; Perin A; Fraccon AP; Lo Re G; Rizzi A; Sava T; Fornarini G; Valcamonico F; Zustovich F; Massari F; Zanardi E; Roma A; Zattoni F; Zagonel V
Clin Genitourin Cancer; 2016 Apr; 14(2):e161-9. PubMed ID: 26775721
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.
Chau C; Cathomas R; Wheater M; Klingbiel D; Fehr M; Bennett J; Markham H; Lee C; Crabb SJ; Geldart T
Ann Oncol; 2015 Sep; 26(9):1865-1870. PubMed ID: 26037797
[TBL] [Abstract][Full Text] [Related]
18. Phase II study: adjuvant single-agent carboplatin therapy for clinical stage I seminoma.
Krege S; Kalund G; Otto T; Goepel M; Rübben H
Eur Urol; 1997; 31(4):405-7. PubMed ID: 9187898
[TBL] [Abstract][Full Text] [Related]
19. Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group.
Tandstad T; Smaaland R; Solberg A; Bremnes RM; Langberg CW; Laurell A; Stierner UK; Ståhl O; Cavallin-Ståhl EK; Klepp OH; Dahl O; Cohn-Cedermark G
J Clin Oncol; 2011 Feb; 29(6):719-25. PubMed ID: 21205748
[TBL] [Abstract][Full Text] [Related]
20. Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study.
Aparicio J; Maroto P; del Muro XG; Gumà J; Sánchez-Muñoz A; Margelí M; Doménech M; Bastús R; Fernández A; López-Brea M; Terrassa J; Meana A; del Prado PM; Sastre J; Satrústegui JJ; Gironés R; Robert L; Germà JR
J Clin Oncol; 2011 Dec; 29(35):4677-81. PubMed ID: 22042940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]